These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. LncRNA TUG1 inhibits the proliferation and fibrosis of mesangial cells in diabetic nephropathy via inhibiting the PI3K/AKT pathway. Zang XJ, Li L, Du X, Yang B, Mei CL. Eur Rev Med Pharmacol Sci; 2019 Sep; 23(17):7519-7525. PubMed ID: 31539141 [Abstract] [Full Text] [Related]
5. YAP mediates the interaction between the Hippo and PI3K/Akt pathways in mesangial cell proliferation in diabetic nephropathy. Qian X, He L, Hao M, Li Y, Li X, Liu Y, Jiang H, Xu L, Li C, Wu W, Du L, Yin X, Lu Q. Acta Diabetol; 2021 Jan; 58(1):47-62. PubMed ID: 32816106 [Abstract] [Full Text] [Related]
12. The Long Noncoding RNA 150Rik Promotes Mesangial Cell Proliferation via miR-451/IGF1R/p38 MAPK Signaling in Diabetic Nephropathy. Zhang Y, Sun Y, Peng R, Liu H, He W, Zhang L, Peng H, Zhang Z. Cell Physiol Biochem; 2018 Apr 01; 51(3):1410-1428. PubMed ID: 30485837 [Abstract] [Full Text] [Related]
14. LncRNA lnc-ISG20 promotes renal fibrosis in diabetic nephropathy by inducing AKT phosphorylation through miR-486-5p/NFAT5. Duan YR, Chen BP, Chen F, Yang SX, Zhu CY, Ma YL, Li Y, Shi J. J Cell Mol Med; 2021 Jun 01; 25(11):4922-4937. PubMed ID: 33939247 [Abstract] [Full Text] [Related]
20. Knockdown of lncRNA OGFRP1 Inhibits Proliferation and Invasion of JEG-3 Cells Via AKT/mTOR Pathway. Meng Q, Xue H. Technol Cancer Res Treat; 2020 Jul 01; 19():1533033820905823. PubMed ID: 32233835 [Abstract] [Full Text] [Related] Page: [Next] [New Search]